{"count":44,"next":"https://lda.gov/api/v1/filings/?filing_specific_lobbying_issues=H.R.+3521&filing_year=2026&ordering=-filing_year&page=2","previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/bf79e7b9-4135-4425-81a6-e51ff02d3249/","filing_uuid":"bf79e7b9-4135-4425-81a6-e51ff02d3249","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/bf79e7b9-4135-4425-81a6-e51ff02d3249/print/","filing_document_content_type":"text/html","income":null,"expenses":"226164.69","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Taylor Sabol","dt_posted":"2026-04-06T21:12:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1400 K St NW Ste 400","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":27582,"url":"https://lda.gov/api/v1/registrants/27582/","house_registrant_id":32137,"name":"NATIONAL COUNCIL FOR BEHAVIORAL HEALTH","description":"trade association, advocacy for community mental health and addiction services","address_1":"1701 K Street, NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PETER DELIA","contact_telephone":"+1 954-609-0253","dt_updated":"2026-07-01T11:04:03.643536-04:00"},"client":{"id":134301,"url":"https://lda.gov/api/v1/clients/134301/","client_id":12,"name":"NATIONAL COUNCIL FOR BEHAVIORAL HEALTH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-16"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"SUPPORT for Patients and Communities Reauthorization Act (H.R. 2483), all provisions related to the continued bolstered funding for substance use disorder treatment and recovery. Ensuring Excellence in Mental Health Act (S.3402), all provisions relating to certified community behavioral health clinics. COMPLETE Care Act (S. 931/H.R. 2509), all provisions related to providing incentives for behavioral health integration. STAR Plus Scholarship Act (H.R. 3655), all provisions related to creating a scholarship program for students pursuing a degree to provide substance use disorder treatment, mental health and behavioral health services. PEER Support Act (H.R. 2741/S. 1329), all provisions related to background screenings for peer specialists, creating a statutory definition in the Medicare program for peer specialists, and establishing the Office of Recovery. EARLY Minds Act (S. 779/H.R. 1735), all provisions related to allowing states to allocate up to five percent of their Mental Health Block Grant funding for prevention and early intervention activities. Building Capacity for Care Act (H.R. 2223), all provisions related to creating grants, loans, and loan guarantees to fund the construction, renovation, or purchase of behavioral health facilities that provide short-term inpatient care, partial hospitalization, intensive outpatient care, and/or crisis stabilization. Expanding Student Access to Mental Health Services Act (H.R. 1649), all provisions related to improving mental health services for students. PEER Mental Health Act (H.R. 1448), all provisions related to awarding grants to train teachers, school personnel, parents/caregivers and students in mental health first aid. Parity Enforcement Act (H.R. 957), all provisions related to imposing civil monetary penalties for violations of mental health parity requirements. Telehealth Access for Tribal Communities Act of 2025 (H.R. 2639), all provisions related to providing access to healthcare services through audio-only telehealth for Medicare beneficiaries in tribal communities. Treatment and Homelessness Housing Integration Act of 2024 (H.R. 577), all provisions related to establishing a five-year demonstration program to refer qualified participants within the Continuum of Care Program to the nearest Certified Community Behavioral Health Clinic. Veteran Overmedication and Suicide Prevention Act of 2025(H.R. 136), all provisions relating to requiring the Department of Veterans Affairs (VA) to contract with the National Academies of Sciences, Engineering, and Medicine to report on the deaths of covered veterans who died by suicide during the last five years. Farmers First Act (H.R. 4400/S. 2282), all provisions related to grant recipients under the bill establishing referral relationships with Certified Community Behavioral Health Clinics. Mental Health Services for Students Act (H.R. 5557), all provisions related to bringing mental health services to students in public schools across the country and provide federal funding for school-based mental health programs to address the nations youth mental health crisis. Campus Prevention and Recovery Services Act (Not yet introduced), all provisions related to revising the illicit drug and alcohol abuse prevention program, including by expanding the program to include efforts to prevent substance misuse on campuses Community Mental Wellness Worker Training Act (H.R. 5733), all provisions related to awarding award grants to eligible entities to implement community mental wellness worker training grants. PEERS in Medicare Act (H.R. 6748/S. 3521), all provisions related to permitting reimbursement of peer support services under Medicare in different community-based settings. LEAP Act (H.R. 6574), all provisions relating to equal treatment for loan eligibility among graduate degree programs. Home-Based Telemental Health Care Act of 2025 (S. 1056), all provisions relating to expanding access to mental health and substance abuse services for rural patients, particularly for individuals in the farming, fishing, and forestry industries. Written Informed Consent Act (H.R. 4837/S. 3314), all provisions relating to providing written consent to VA patients when prescribing certain drugs. No Red Tape for Addiction Treatment Act (S.3522), all provisions relating to requiring state Medicaid programs to cover at least one formulation of each FDA-approved medication for opioid use disorder without prior authorization when medically appropriate. Mental Health Access and Provider Support Act (S. 4202/H.R. 8081), all provisions relating to increasing Medicare reimbursement for behavioral health providers. STOP Suicide Act (H.R.8124), all provisions relating to creating a grant program at SAMHSA to expand the use of evidence-based models for stabilizing individuals with serious thoughts of suicide","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71664,"prefix":null,"prefix_display":null,"first_name":"REYNA","nickname":null,"middle_name":null,"last_name":"TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Reentry Act of 2025 (H.R. 2586), all provisions related to allowing Medicaid coverage for eligible incarcerated individuals to be re-established up to 30 days before their release from jail or prison. Due Process Continuity of Care Act (H.R. 1510), all provisions related to amending the Medicaid Inmate Exclusion Policy to allow incarcerated individuals to sustain their Medicaid coverage prior to a conviction.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71664,"prefix":null,"prefix_display":null,"first_name":"REYNA","nickname":null,"middle_name":null,"last_name":"TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Labor, Health and Human Services, Education and Related Agencies appropriations, support of funding for mental health and substance use programs including the Certified Community Behavioral Health Clinic Expansion (CCBHC-E) program, Mental Health Awareness Training (MHAT), Primary and Behavioral Health Care Integration (PBHCI) Grants and Technical Assistance, Substance Use Prevention, Treatment, and Recovery Services Block Grant (SUPTRS BG), Community Mental Health Service Block Grant (MHBG), and State Opioid Response (SOR) grants. Commerce, Justice, Science and Related Agencies appropriations, support of funding for the Crisis Stabilization and Community Reentry program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71664,"prefix":null,"prefix_display":null,"first_name":"REYNA","nickname":null,"middle_name":null,"last_name":"TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOU","general_issue_code_display":"Housing","description":"American Affordability Act (H.R. 6900), all provisions relating to health care affordability.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71664,"prefix":null,"prefix_display":null,"first_name":"REYNA","nickname":null,"middle_name":null,"last_name":"TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3fd8b296-e504-4946-9d39-fde5ba084aa0/","filing_uuid":"3fd8b296-e504-4946-9d39-fde5ba084aa0","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/3fd8b296-e504-4946-9d39-fde5ba084aa0/print/","filing_document_content_type":"text/html","income":null,"expenses":"210000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"8r1","dt_posted":"2026-04-15T11:09:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2318 Mill Rd","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":401105592,"url":"https://lda.gov/api/v1/registrants/401105592/","house_registrant_id":null,"name":"ASSOCIATION FOR CLINICAL ONCOLOGY","description":"physician medical specialty society","address_1":"2318 Mill Rd","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22314","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY PEREZ","contact_telephone":"+1 571-483-1496","dt_updated":"2026-07-21T14:12:19.395401-04:00"},"client":{"id":205751,"url":"https://lda.gov/api/v1/clients/205751/","client_id":12,"name":"ASSOCIATION FOR CLINICAL ONCOLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-01-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. S. 1640/H.R. 879: Medicare Patient Access and Practice Stabilization Act of 2025 - This bill increases certain payment adjustments under the Medicare physician fee schedule for services furnished between April 1, 2025, and January 1, 2026. S. 1460/H.R. 786: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 2120/S. 1031: ROCR Value Based Program Act - establishes a new payment program for radiation oncology services, focusing on stable payments, quality care, and patient access, while exempting it from budget neutrality adjustments. H.R. 4559: Prompt and Fair Pay Act - to establish payment parity between Medicare Advantage and fee-for-service Medicare, and to establish prompt payment requirements under Medicare Advantage. H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act - provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation. H.R. 5081/S. 2709: Telehealth Modernization Act - to extend certain telehealth flexibilities under the Medicare program. H.R. 4752/S. 2760: Reducing Hereditary Cancer Act - to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":120202,"prefix":null,"prefix_display":null,"first_name":"KRISTINE","nickname":null,"middle_name":null,"last_name":"RUFENER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141122,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"GIFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 6423/S. 864: HELP Copays Act - requires health insurers to count third-party financial assistance toward patients' cost-sharing obligations, including deductibles and copays, for prescription drugs, with changes effective for plan years beginning January 1, 2026. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 1262/S. 932: Mikaela Naylon Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":120202,"prefix":null,"prefix_display":null,"first_name":"KRISTINE","nickname":null,"middle_name":null,"last_name":"RUFENER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141122,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"GIFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP). FY 2027 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":120202,"prefix":null,"prefix_display":null,"first_name":"KRISTINE","nickname":null,"middle_name":null,"last_name":"RUFENER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141122,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"GIFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2147d217-3c07-4791-aa43-a6065c5cf34c/","filing_uuid":"2147d217-3c07-4791-aa43-a6065c5cf34c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2147d217-3c07-4791-aa43-a6065c5cf34c/print/","filing_document_content_type":"text/html","income":null,"expenses":"2300000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Nickson","dt_posted":"2026-04-20T12:21:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th St, NW","registrant_address_2":"Suite 503","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":288670,"url":"https://lda.gov/api/v1/registrants/288670/","house_registrant_id":37100,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.","description":null,"address_1":"655 15th St, NW","address_2":"Suite 503","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE NICKSON","contact_telephone":"+1 202-320-3064","dt_updated":"2026-07-28T09:35:13.201222-04:00"},"client":{"id":177221,"url":"https://lda.gov/api/v1/clients/177221/","client_id":12,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Health Disparities Nancy Gardner Sewell Medicare Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010) Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13)(2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1) (2007-2023); Intern, Senator Barack Obama (D-IL) (2005)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson(D - FL 24) (2011)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, U.S. Representative Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2147d217-3c07-4791-aa43-a6065c5cf34c/","filing_uuid":"2147d217-3c07-4791-aa43-a6065c5cf34c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2147d217-3c07-4791-aa43-a6065c5cf34c/print/","filing_document_content_type":"text/html","income":null,"expenses":"2300000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Nickson","dt_posted":"2026-04-20T12:21:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th St, NW","registrant_address_2":"Suite 503","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":288670,"url":"https://lda.gov/api/v1/registrants/288670/","house_registrant_id":37100,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.","description":null,"address_1":"655 15th St, NW","address_2":"Suite 503","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE NICKSON","contact_telephone":"+1 202-320-3064","dt_updated":"2026-07-28T09:35:13.201222-04:00"},"client":{"id":177221,"url":"https://lda.gov/api/v1/clients/177221/","client_id":12,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Health Disparities Nancy Gardner Sewell Medicare Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010) Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13)(2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1) (2007-2023); Intern, Senator Barack Obama (D-IL) (2005)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson(D - FL 24) (2011)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, U.S. Representative Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2147d217-3c07-4791-aa43-a6065c5cf34c/","filing_uuid":"2147d217-3c07-4791-aa43-a6065c5cf34c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2147d217-3c07-4791-aa43-a6065c5cf34c/print/","filing_document_content_type":"text/html","income":null,"expenses":"2300000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Nickson","dt_posted":"2026-04-20T12:21:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th St, NW","registrant_address_2":"Suite 503","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":288670,"url":"https://lda.gov/api/v1/registrants/288670/","house_registrant_id":37100,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.","description":null,"address_1":"655 15th St, NW","address_2":"Suite 503","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE NICKSON","contact_telephone":"+1 202-320-3064","dt_updated":"2026-07-28T09:35:13.201222-04:00"},"client":{"id":177221,"url":"https://lda.gov/api/v1/clients/177221/","client_id":12,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Health Disparities Nancy Gardner Sewell Medicare Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010) Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13)(2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1) (2007-2023); Intern, Senator Barack Obama (D-IL) (2005)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson(D - FL 24) (2011)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, U.S. Representative Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/","filing_uuid":"a6e62edd-dc28-4d2f-8d0d-a44c10015a10","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/print/","filing_document_content_type":"text/html","income":null,"expenses":"160000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-04-20T13:16:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act; SHOWER Act; Affordable HOMES Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/","filing_uuid":"a6e62edd-dc28-4d2f-8d0d-a44c10015a10","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/a6e62edd-dc28-4d2f-8d0d-a44c10015a10/print/","filing_document_content_type":"text/html","income":null,"expenses":"160000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-04-20T13:16:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act; SHOWER Act; Affordable HOMES Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e3beff28-2272-4f88-b28c-e7fa63e13ebd/","filing_uuid":"e3beff28-2272-4f88-b28c-e7fa63e13ebd","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e3beff28-2272-4f88-b28c-e7fa63e13ebd/print/","filing_document_content_type":"text/html","income":null,"expenses":"3510000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jane Adams","dt_posted":"2026-04-20T16:34:13-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"ONE JOHNSON & JOHNSON PLAZA","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"NEW BRUNSWICK","registrant_state":"NJ","registrant_zip":"08933","registrant":{"id":20686,"url":"https://lda.gov/api/v1/registrants/20686/","house_registrant_id":30348,"name":"JOHNSON & JOHNSON SERVICES, INC.","description":null,"address_1":"ONE JOHNSON & JOHNSON PLAZA","address_2":null,"address_3":null,"address_4":null,"city":"NEW BRUNSWICK","state":"NJ","state_display":"New Jersey","zip":"08933","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JANE ADAMS","contact_telephone":"+1 202-589-1000","dt_updated":"2026-07-30T18:01:40.268804-04:00"},"client":{"id":126906,"url":"https://lda.gov/api/v1/clients/126906/","client_id":12,"name":"JOHNSON & JOHNSON SERVICES INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":91402,"prefix":null,"prefix_display":null,"first_name":"DEANA","nickname":null,"middle_name":null,"last_name":"MCRAE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71075,"prefix":null,"prefix_display":null,"first_name":"LARRY","nickname":null,"middle_name":null,"last_name":"CAMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73113,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"PINKELE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150724,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":null,"last_name":"KALUSNIAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153683,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"LAST","suffix":null,"suffix_display":null},"covered_position":"Sen. PA, Senate HELP Committee (2025); PA, Sen. Cornyn (2017-2022, 2023-2025); Sen. LA, Rep. Brady (2017); Sen. LA, Rep. Lance (2009-2012); LC/LA Rep. Knollenberg (2006-2008).","new":true},{"lobbyist":{"id":153684,"prefix":null,"prefix_display":null,"first_name":"FOLASHADE","nickname":null,"middle_name":null,"last_name":"WILSON","suffix":null,"suffix_display":null},"covered_position":"Health Fellow, Office of Robin Kelly (Sept 2024-Sept 2025); Health Fellow, Office of Bernard Sanders (Sept 2024-Oct 2025).","new":true},{"lobbyist":{"id":153685,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"CLARKIN","suffix":null,"suffix_display":null},"covered_position":"Legislative Director for Rep. Brian Fitzpatrick (March 2025-January 2026)","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"- Issues related to stroke care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"- H.R. 2483, \"SUPPORT for Patients and Communities Reauthorization Act of 2025\", regarding all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Issues related to - artificial intelligence - data privacy - cybersecurity - robotics","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax - use of excess pension funds","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":91402,"prefix":null,"prefix_display":null,"first_name":"DEANA","nickname":null,"middle_name":null,"last_name":"MCRAE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"- Issues related to USMCA review and renegotiation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/f0278881-e5bd-4643-98c6-138243768f63/","filing_uuid":"f0278881-e5bd-4643-98c6-138243768f63","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/f0278881-e5bd-4643-98c6-138243768f63/print/","filing_document_content_type":"text/html","income":null,"expenses":"860000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Matt Willams, Vice President US Government Affairs","dt_posted":"2026-04-20T17:57:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"6555 State Highway 161","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Irving","registrant_state":"TX","registrant_zip":"75039","registrant":{"id":24566,"url":"https://lda.gov/api/v1/registrants/24566/","house_registrant_id":31313,"name":"MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY","description":null,"address_1":"6555 State Highway 161","address_2":null,"address_3":null,"address_4":null,"city":"Irving","state":"TX","state_display":"Texas","zip":"75039","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT WILLIAMS","contact_telephone":"+1 972-446-4800","dt_updated":"2026-10-21T11:54:10.352735-04:00"},"client":{"id":132410,"url":"https://lda.gov/api/v1/clients/132410/","client_id":12,"name":"MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-09"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors);S. 3822, Break Up Big Medicine Act; Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":80345,"prefix":null,"prefix_display":null,"first_name":"JOSHUA","nickname":null,"middle_name":"C","last_name":"BABB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148622,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61981,"prefix":null,"prefix_display":null,"first_name":"BEN","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140654,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146847,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"BUCKLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149849,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BRANTON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink","new":false},{"lobbyist":{"id":149850,"prefix":null,"prefix_display":null,"first_name":"DIANA","nickname":null,"middle_name":null,"last_name":"FELNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150570,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"RICHARDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149849,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BRANTON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink","new":false},{"lobbyist":{"id":80345,"prefix":null,"prefix_display":null,"first_name":"JOSHUA","nickname":null,"middle_name":"C","last_name":"BABB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148622,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61981,"prefix":null,"prefix_display":null,"first_name":"BEN","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140654,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150570,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"RICHARDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149850,"prefix":null,"prefix_display":null,"first_name":"DIANA","nickname":null,"middle_name":null,"last_name":"FELNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R. 3164, Ensuring Community Access to Pharmacist Services Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":80345,"prefix":null,"prefix_display":null,"first_name":"JOSHUA","nickname":null,"middle_name":"C","last_name":"BABB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148622,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146847,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"BUCKLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149849,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BRANTON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink","new":false},{"lobbyist":{"id":149850,"prefix":null,"prefix_display":null,"first_name":"DIANA","nickname":null,"middle_name":null,"last_name":"FELNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"H.R. 2444, Promoting Resilient Supply Chains Act; S.257, Promoting Resilient Supply Chains","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146847,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"BUCKLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148622,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":80345,"prefix":null,"prefix_display":null,"first_name":"JOSHUA","nickname":null,"middle_name":"C","last_name":"BABB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149850,"prefix":null,"prefix_display":null,"first_name":"DIANA","nickname":null,"middle_name":null,"last_name":"FELNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149849,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BRANTON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e3e6e777-1c9e-437b-b1e1-2863dec54d68/","filing_uuid":"e3e6e777-1c9e-437b-b1e1-2863dec54d68","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e3e6e777-1c9e-437b-b1e1-2863dec54d68/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"ERIC J SILVA","dt_posted":"2026-04-20T18:23:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"5614 Connecticut Avenue, NW","registrant_address_2":"#204","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20015","registrant":{"id":400689052,"url":"https://lda.gov/api/v1/registrants/400689052/","house_registrant_id":41501,"name":"NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC","description":"Consulting Firm","address_1":"5614 Connecticut Avenue, NW","address_2":"#204","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20015","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN MCMICKLE","contact_telephone":"+1 202-468-2197","dt_updated":"2026-10-20T12:55:48.803284-04:00"},"client":{"id":66228,"url":"https://lda.gov/api/v1/clients/66228/","client_id":66228,"name":"MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER","general_description":"Distribution","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63360,"prefix":null,"prefix_display":null,"first_name":"ERIC","nickname":null,"middle_name":"J.","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":"Legislative Aide, Senate EPW & Senator James Jeffords","new":false},{"lobbyist":{"id":150823,"prefix":null,"prefix_display":null,"first_name":"REILLY","nickname":null,"middle_name":null,"last_name":"O'CONNOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63360,"prefix":null,"prefix_display":null,"first_name":"ERIC","nickname":null,"middle_name":"J.","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150823,"prefix":null,"prefix_display":null,"first_name":"REILLY","nickname":null,"middle_name":null,"last_name":"O'CONNOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R. 3164, Ensuring Community Access to Pharmacist Services Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63360,"prefix":null,"prefix_display":null,"first_name":"ERIC","nickname":null,"middle_name":"J.","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150823,"prefix":null,"prefix_display":null,"first_name":"REILLY","nickname":null,"middle_name":null,"last_name":"O'CONNOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"H.R. 2444, Promoting Resilient Supply Chains Act; S. 257, Promoting Resilient Supply Chains","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63360,"prefix":null,"prefix_display":null,"first_name":"ERIC","nickname":null,"middle_name":"J.","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150823,"prefix":null,"prefix_display":null,"first_name":"REILLY","nickname":null,"middle_name":null,"last_name":"O'CONNOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/53111570-8a2a-4a27-b0f6-63ba861324a2/","filing_uuid":"53111570-8a2a-4a27-b0f6-63ba861324a2","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/53111570-8a2a-4a27-b0f6-63ba861324a2/print/","filing_document_content_type":"text/html","income":null,"expenses":"19500.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Timothy Clement","dt_posted":"2026-05-04T10:12:34-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"500 Montgomery Street","registrant_address_2":"Suite 820","registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":28195,"url":"https://lda.gov/api/v1/registrants/28195/","house_registrant_id":32140,"name":"MENTAL HEALTH AMERICA","description":null,"address_1":"2000 North Beauregard Street","address_2":"6th Floor","address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22311","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NATHANIEL COUNTS","contact_telephone":"+1 703-797-2583","dt_updated":"2024-07-22T14:54:01.761266-04:00"},"client":{"id":134498,"url":"https://lda.gov/api/v1/clients/134498/","client_id":12,"name":"MENTAL HEALTH AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1996-02-14"},"lobbying_activities":[{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Mental Health Substance use disorder H.R. 1, One Big Beautiful Bill Act; specifically, lobbying to amend Medicaid community engagement requirements to require states to perform ex parte verifications for individuals eligible for exceptions due to having a substance use disorder; lobbying House Energy and Commerce (majority and minority) and Senate HELP (majority and minority) on legislative language related to ex-parte verifications and 42 CFR Part 2 that would improve implementation of H.R. 1","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146924,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"CLEMENT","suffix":null,"suffix_display":null},"covered_position":"Vice President of Federal Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations for Mental Health Block Grant at levels contained within H.R. 5304 Appropriations for Parity Enforcement Grants within Center for Consumer Information and Insurance Oversight","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146924,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"CLEMENT","suffix":null,"suffix_display":null},"covered_position":"Vice President of Federal Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Early Action and Responsiveness Lifts Youth Minds Act H.R. 1735/S.779. Legislation that would allow states to use up to 5% of the Mental Health Block Grant for evidence-based mental health prevention and early intervention activities. REAL Health Providers Act, H.R. 5281. This bill requires Medicare Advantage (MA) organizations to maintain directories of in-network providers and continually ensure their accuracy. Specifically, MA organizations must publish on their websites an accurate directory of in-network providers and regularly update these directories. The bill additionally specifies that if a provider is listed as in-network in this directory when a beneficiary selects and makes an appointment with the provider, but the provider is not actually in-network, the beneficiary is still only responsible for paying in-network cost-sharing requirements. MA organizations must annually evaluate and report on the accuracy of their directories; the Centers for Medicare & Medicaid Services and MA organizations must publish this information on their websites. The bill provides funds for these purposes. The Government Accountability Office must report on the bill's implementation. COMPLETE Care Act (S.931/H.R.2509). This bill would increase Medicare reimbursement amounts for the HCPCS billing codes for integrated behavioral health care for three years. The HCPCS codes are 99484, 99492, 99493, 99494, G2214, and G0323. Reimbursement would be 175% of current rates for 2027, 150% for 2028, and 125% for 2029. Promoting Effective and Empowering Recovery Services in Medicare Act H.R. 6841/S. 3521. This bill would allow for Medicare reimbursement for mental health and substance use disorder peer support specialists.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146924,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"CLEMENT","suffix":null,"suffix_display":null},"covered_position":"Vice President of Federal Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill (H.R. 1). Specifically, lobbying House Energy and Commerce and Senate HELP committees to ask administration to clarify the effect of 42 CFR Part 2 on ex-parte verifications of individuals who are exempt from community engagement requirements.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146924,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"CLEMENT","suffix":null,"suffix_display":null},"covered_position":"Vice President of Federal Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/bf3a4125-c1c7-45ff-b279-3fef17f43caf/","filing_uuid":"bf3a4125-c1c7-45ff-b279-3fef17f43caf","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/bf3a4125-c1c7-45ff-b279-3fef17f43caf/print/","filing_document_content_type":"text/html","income":null,"expenses":"150554.77","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Taylor Sabol","dt_posted":"2026-07-08T09:20:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1400 K St NW Ste 400","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":27582,"url":"https://lda.gov/api/v1/registrants/27582/","house_registrant_id":32137,"name":"NATIONAL COUNCIL FOR BEHAVIORAL HEALTH","description":"trade association, advocacy for community mental health and addiction services","address_1":"1701 K Street, NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PETER DELIA","contact_telephone":"+1 954-609-0253","dt_updated":"2026-07-01T11:04:03.643536-04:00"},"client":{"id":134301,"url":"https://lda.gov/api/v1/clients/134301/","client_id":12,"name":"NATIONAL COUNCIL FOR BEHAVIORAL HEALTH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-16"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"SUPPORT for Patients and Communities Reauthorization Act (H.R. 2483), all provisions related to the continued bolstered funding for substance use disorder treatment and recovery. Ensuring Excellence in Mental Health Act (S.3402), all provisions relating to certified community behavioral health clinics. COMPLETE Care Act (S. 931/H.R. 2509), all provisions related to providing incentives for behavioral health integration. STAR Plus Scholarship Act (H.R. 3655), all provisions related to creating a scholarship program for students pursuing a degree to provide substance use disorder treatment, mental health and behavioral health services. PEER Support Act (H.R. 2741/S. 1329), all provisions related to background screenings for peer specialists, creating a statutory definition in the Medicare program for peer specialists, and establishing the Office of Recovery. EARLY Minds Act (S. 779/H.R. 1735), all provisions related to allowing states to allocate up to five percent of their Mental Health Block Grant funding for prevention and early intervention activities. WORK to Save Lives Act (H.R. 7479/S. 3812), all provisions related to requiring guidance for maintenance and training on opioid reversal medications in the workplace. Building Capacity for Care Act (H.R. 2223), all provisions related to creating grants, loans, and loan guarantees to fund the construction, renovation, or purchase of behavioral health facilities that provide short-term inpatient care, partial hospitalization, intensive outpatient care, and/or crisis stabilization. Expanding Student Access to Mental Health Services Act (H.R. 1649), all provisions related to improving mental health services for students. PEER Mental Health Act (H.R. 1448), all provisions related to awarding grants to train teachers, school personnel, parents/caregivers and students in mental health first aid. Parity Enforcement Act (H.R. 957), all provisions related to imposing civil monetary penalties for violations of mental health parity requirements. Telehealth Access for Tribal Communities Act of 2025 (H.R. 2639), all provisions related to providing access to healthcare services through audio-only telehealth for Medicare beneficiaries in tribal communities. Treatment and Homelessness Housing Integration Act of 2024 (H.R. 577), all provisions related to establishing a five-year demonstration program to refer qualified participants within the Continuum of Care Program to the nearest Certified Community Behavioral Health Clinic. Veteran Overmedication and Suicide Prevention Act of 2025(H.R. 136), all provisions relating to requiring the Department of Veterans Affairs (VA) to contract with the National Academies of Sciences, Engineering, and Medicine to report on the deaths of covered veterans who died by suicide during the last five years. Farmers First Act (H.R. 4400/S. 2282), all provisions related to grant recipients under the bill establishing referral relationships with Certified Community Behavioral Health Clinics. Mental Health Services for Students Act (H.R. 5557), all provisions related to bringing mental health services to students in public schools across the country and provide federal funding for school-based mental health programs to address the nations youth mental health crisis. Campus Prevention and Recovery Services Act (Not yet introduced), all provisions related to revising the illicit drug and alcohol abuse prevention program, including by expanding the program to include efforts to prevent substance misuse on campuses Community Mental Wellness Worker Training Act (H.R. 5733), all provisions related to awarding award grants to eligible entities to implement community mental wellness worker training grants. PEERS Act (H.R. 6841/S. 3521), all provisions related to permitting reimbursement of peer support services under Medicare in different community-based settings. LEAP Act (H.R. 6574), all provisions relating to equal treatment for loan eligibility among graduate degree programs. Home-Based Telemental Health Care Act of 2025 (S. 1056), all provisions relating to expanding access to mental health and substance abuse services for rural patients, particularly for individuals in the farming, fishing, and forestry industries. Written Informed Consent Act (H.R. 4837/S. 3314), all provisions relating to providing written consent to VA patients when prescribing certain drugs. No Red Tape for Addiction Treatment Act (S.3522), all provisions relating to requiring state Medicaid programs to cover at least one formulation of each FDA-approved medication for opioid use disorder without prior authorization when medically appropriate. Mental Health Access and Provider Support Act (S. 4202/H.R. 8081), all provisions relating to increasing Medicare reimbursement for behavioral health providers. STOP Suicide Act (H.R.8124), all provisions relating to creating a grant program at SAMHSA to expand the use of evidence-based models for stabilizing individuals with serious thoughts of suicide","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71664,"prefix":null,"prefix_display":null,"first_name":"REYNA","nickname":null,"middle_name":null,"last_name":"TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Reentry Act of 2025 (H.R. 2586), all provisions related to allowing Medicaid coverage for eligible incarcerated individuals to be re-established up to 30 days before their release from jail or prison. Due Process Continuity of Care Act (H.R. 1510), all provisions related to amending the Medicaid Inmate Exclusion Policy to allow incarcerated individuals to sustain their Medicaid coverage prior to a conviction.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71664,"prefix":null,"prefix_display":null,"first_name":"REYNA","nickname":null,"middle_name":null,"last_name":"TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Labor, Health and Human Services, Education and Related Agencies appropriations, support of funding for mental health and substance use programs including the Certified Community Behavioral Health Clinic Expansion (CCBHC-E) program, Mental Health Awareness Training (MHAT), Primary and Behavioral Health Care Integration (PBHCI) Grants and Technical Assistance, Substance Use Prevention, Treatment, and Recovery Services Block Grant (SUPTRS BG), Community Mental Health Service Block Grant (MHBG), and State Opioid Response (SOR) grants. Commerce, Justice, Science and Related Agencies appropriations, support of funding for the Crisis Stabilization and Community Reentry program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71664,"prefix":null,"prefix_display":null,"first_name":"REYNA","nickname":null,"middle_name":null,"last_name":"TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOU","general_issue_code_display":"Housing","description":"American Affordability Act (H.R. 6900), all provisions relating to health care affordability.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71664,"prefix":null,"prefix_display":null,"first_name":"REYNA","nickname":null,"middle_name":null,"last_name":"TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/67b5714f-7362-43a2-86fd-22759280fe17/","filing_uuid":"67b5714f-7362-43a2-86fd-22759280fe17","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/67b5714f-7362-43a2-86fd-22759280fe17/print/","filing_document_content_type":"text/html","income":null,"expenses":"890000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-07-16T16:09:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S. ___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S._____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. ___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act HR 5509, Safe Step Act, Provisions related step therapy protocols H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7391, the Community Health Center Drug Pricing Protection Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First S. 891, Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S.4784, An original bill to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes, Provisions related to the pharmaceutical industry. Smucker's VICP bill Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Vaccine policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 9102: Biotech Investment National Security Act (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/250a8f15-4b58-4412-b97f-a83302b24d02/","filing_uuid":"250a8f15-4b58-4412-b97f-a83302b24d02","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/250a8f15-4b58-4412-b97f-a83302b24d02/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"ERIC J SILVA","dt_posted":"2026-07-17T16:34:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"5614 Connecticut Avenue, NW","registrant_address_2":"#204","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20015","registrant":{"id":400689052,"url":"https://lda.gov/api/v1/registrants/400689052/","house_registrant_id":41501,"name":"NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC","description":"Consulting Firm","address_1":"5614 Connecticut Avenue, NW","address_2":"#204","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20015","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN MCMICKLE","contact_telephone":"+1 202-468-2197","dt_updated":"2026-10-20T12:55:48.803284-04:00"},"client":{"id":66228,"url":"https://lda.gov/api/v1/clients/66228/","client_id":66228,"name":"MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER","general_description":"Distribution","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases). Issues related to support for independent physician practices, community pharmacies, and community-based care.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63360,"prefix":null,"prefix_display":null,"first_name":"ERIC","nickname":null,"middle_name":"J.","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":"Legislative Aide, Senate EPW & Senator James Jeffords","new":false},{"lobbyist":{"id":150823,"prefix":null,"prefix_display":null,"first_name":"REILLY","nickname":null,"middle_name":null,"last_name":"O'CONNOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63360,"prefix":null,"prefix_display":null,"first_name":"ERIC","nickname":null,"middle_name":"J.","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150823,"prefix":null,"prefix_display":null,"first_name":"REILLY","nickname":null,"middle_name":null,"last_name":"O'CONNOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R. 3164, Ensuring Community Access to Pharmacist Services Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63360,"prefix":null,"prefix_display":null,"first_name":"ERIC","nickname":null,"middle_name":"J.","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150823,"prefix":null,"prefix_display":null,"first_name":"REILLY","nickname":null,"middle_name":null,"last_name":"O'CONNOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"H.R. 2444, Promoting Resilient Supply Chains Act; S. 257, Promoting Resilient Supply Chains","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63360,"prefix":null,"prefix_display":null,"first_name":"ERIC","nickname":null,"middle_name":"J.","last_name":"SILVA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150823,"prefix":null,"prefix_display":null,"first_name":"REILLY","nickname":null,"middle_name":null,"last_name":"O'CONNOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/08ded1c1-72aa-4852-a6d4-6b85061232c3/","filing_uuid":"08ded1c1-72aa-4852-a6d4-6b85061232c3","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/08ded1c1-72aa-4852-a6d4-6b85061232c3/print/","filing_document_content_type":"text/html","income":"70000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Molly Ford","dt_posted":"2026-07-17T17:00:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2001 K Street, NW","registrant_address_2":"Third Floor North","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":35684,"url":"https://lda.gov/api/v1/registrants/35684/","house_registrant_id":31728,"name":"SMITHBUCKLIN CORPORATION","description":"Trade association","address_1":"2001 K Street, NW","address_2":"Third Floor North","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MOLLY FORD","contact_telephone":"+1 202-367-1100","dt_updated":"2026-07-28T15:46:16.782370-04:00"},"client":{"id":144309,"url":"https://lda.gov/api/v1/clients/144309/","client_id":1003907,"name":"ASTCT","general_description":"Healthcare Society","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-25"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"- Labor-HHS Appropriations - CAR-T Therapy clarification - S. 4440/H.R. 3521, the Clinical Trial Modernization Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141242,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":"GIAMMARCO","middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141242,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":"GIAMMARCO","middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141242,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":"GIAMMARCO","middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/82e28d86-ef96-436b-94df-bdc62fe5ac81/","filing_uuid":"82e28d86-ef96-436b-94df-bdc62fe5ac81","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/82e28d86-ef96-436b-94df-bdc62fe5ac81/print/","filing_document_content_type":"text/html","income":null,"expenses":"1240000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Nickson","dt_posted":"2026-07-20T09:22:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th St, NW","registrant_address_2":"Suite 503","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":288670,"url":"https://lda.gov/api/v1/registrants/288670/","house_registrant_id":37100,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.","description":null,"address_1":"655 15th St, NW","address_2":"Suite 503","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE NICKSON","contact_telephone":"+1 202-320-3064","dt_updated":"2026-07-28T09:35:13.201222-04:00"},"client":{"id":177221,"url":"https://lda.gov/api/v1/clients/177221/","client_id":12,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Mobile Cancer Screening Act, H.R. 4417, S. 2927. The bill would award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential screening services in rural and underserved communities. Breast Cancer Research Stamp Reauthorization Act of 2026, H.R.8358, S.4318. This bill would allow the U.S. Postal Service to extend its authority to issue the Breast Cancer Research semipostal stamp for 10 more years to raise funding for breast cancer research. Recognizing April as Cancer Prevention and Early Detection Month, H.Res.1196. The resolution would uplift the national commitment to cancer prevention and early detection to reduce the cancer burden and improve health outcomes for all Americans. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill would require group health plans and health insurers offering group or individual health insurance coverage to cover specified breast or chest wall reconstruction services related to breast cancer treatment. Medical Records Access Fairness Act, H.R.7790. The bill would require health care providers to give patients free access to their medical records at least once a year. Knock Out Cancer Act (H.R. 3873, or KO Cancer Act). The will would boost National Cancer Institute funding by 25% annually for FY2026-2030 to match cancers mortality toll and direct a report on drug shortages. Health Disparities Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Health Equity and Accountability Act. This bill advances policies to reduce health disparities and improve cancer prevention, research, and care for underserved communities. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Lainie Jones Comprehensive Cancer Survivorship Act, H.R. 8839. The bill would create pathways to address the financial challenges of cancer survivorship and maintain patients access to the health services needed to address the long-term effects of cancer. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Charity Parity Act, H.R. 8783, S. 4511. The bill would allow taxpayers to make direct qualified charitable distributions (QCDs) from their employer sponsored retirement plans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010) Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13)(2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. OMBs proposed Regulation for Federal Financial Assistance (May 2026). The changes in federal regulations would risk politicizing federal grant awards by empowering appointees to override scientific merit reviews, delaying cancer research progress, reducing transparency, and threatening NIH/CDC-funded breakthroughs that save lives.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Asal Sayas National Strategy on Young Adult Cancers Act, S. 4717: Directs the NIH to develop a comprehensive national strategy to address the alarming rise of cancers in adults ages 18 to 49. American Cures Act, S. 4494. This bill would permanently fund several federal agencies and programs that perform biomedical research.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1) (2007-2023); Intern, Senator Barack Obama (D-IL) (2005)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson(D - FL 24) (2011)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, U.S. Representative Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/82e28d86-ef96-436b-94df-bdc62fe5ac81/","filing_uuid":"82e28d86-ef96-436b-94df-bdc62fe5ac81","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/82e28d86-ef96-436b-94df-bdc62fe5ac81/print/","filing_document_content_type":"text/html","income":null,"expenses":"1240000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Nickson","dt_posted":"2026-07-20T09:22:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th St, NW","registrant_address_2":"Suite 503","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":288670,"url":"https://lda.gov/api/v1/registrants/288670/","house_registrant_id":37100,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.","description":null,"address_1":"655 15th St, NW","address_2":"Suite 503","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE NICKSON","contact_telephone":"+1 202-320-3064","dt_updated":"2026-07-28T09:35:13.201222-04:00"},"client":{"id":177221,"url":"https://lda.gov/api/v1/clients/177221/","client_id":12,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Mobile Cancer Screening Act, H.R. 4417, S. 2927. The bill would award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential screening services in rural and underserved communities. Breast Cancer Research Stamp Reauthorization Act of 2026, H.R.8358, S.4318. This bill would allow the U.S. Postal Service to extend its authority to issue the Breast Cancer Research semipostal stamp for 10 more years to raise funding for breast cancer research. Recognizing April as Cancer Prevention and Early Detection Month, H.Res.1196. The resolution would uplift the national commitment to cancer prevention and early detection to reduce the cancer burden and improve health outcomes for all Americans. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill would require group health plans and health insurers offering group or individual health insurance coverage to cover specified breast or chest wall reconstruction services related to breast cancer treatment. Medical Records Access Fairness Act, H.R.7790. The bill would require health care providers to give patients free access to their medical records at least once a year. Knock Out Cancer Act (H.R. 3873, or KO Cancer Act). The will would boost National Cancer Institute funding by 25% annually for FY2026-2030 to match cancers mortality toll and direct a report on drug shortages. Health Disparities Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Health Equity and Accountability Act. This bill advances policies to reduce health disparities and improve cancer prevention, research, and care for underserved communities. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Lainie Jones Comprehensive Cancer Survivorship Act, H.R. 8839. The bill would create pathways to address the financial challenges of cancer survivorship and maintain patients access to the health services needed to address the long-term effects of cancer. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Charity Parity Act, H.R. 8783, S. 4511. The bill would allow taxpayers to make direct qualified charitable distributions (QCDs) from their employer sponsored retirement plans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010) Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13)(2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. OMBs proposed Regulation for Federal Financial Assistance (May 2026). The changes in federal regulations would risk politicizing federal grant awards by empowering appointees to override scientific merit reviews, delaying cancer research progress, reducing transparency, and threatening NIH/CDC-funded breakthroughs that save lives.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Asal Sayas National Strategy on Young Adult Cancers Act, S. 4717: Directs the NIH to develop a comprehensive national strategy to address the alarming rise of cancers in adults ages 18 to 49. American Cures Act, S. 4494. This bill would permanently fund several federal agencies and programs that perform biomedical research.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1) (2007-2023); Intern, Senator Barack Obama (D-IL) (2005)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson(D - FL 24) (2011)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, U.S. Representative Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/82e28d86-ef96-436b-94df-bdc62fe5ac81/","filing_uuid":"82e28d86-ef96-436b-94df-bdc62fe5ac81","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/82e28d86-ef96-436b-94df-bdc62fe5ac81/print/","filing_document_content_type":"text/html","income":null,"expenses":"1240000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Nickson","dt_posted":"2026-07-20T09:22:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th St, NW","registrant_address_2":"Suite 503","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":288670,"url":"https://lda.gov/api/v1/registrants/288670/","house_registrant_id":37100,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.","description":null,"address_1":"655 15th St, NW","address_2":"Suite 503","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE NICKSON","contact_telephone":"+1 202-320-3064","dt_updated":"2026-07-28T09:35:13.201222-04:00"},"client":{"id":177221,"url":"https://lda.gov/api/v1/clients/177221/","client_id":12,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Mobile Cancer Screening Act, H.R. 4417, S. 2927. The bill would award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential screening services in rural and underserved communities. Breast Cancer Research Stamp Reauthorization Act of 2026, H.R.8358, S.4318. This bill would allow the U.S. Postal Service to extend its authority to issue the Breast Cancer Research semipostal stamp for 10 more years to raise funding for breast cancer research. Recognizing April as Cancer Prevention and Early Detection Month, H.Res.1196. The resolution would uplift the national commitment to cancer prevention and early detection to reduce the cancer burden and improve health outcomes for all Americans. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill would require group health plans and health insurers offering group or individual health insurance coverage to cover specified breast or chest wall reconstruction services related to breast cancer treatment. Medical Records Access Fairness Act, H.R.7790. The bill would require health care providers to give patients free access to their medical records at least once a year. Knock Out Cancer Act (H.R. 3873, or KO Cancer Act). The will would boost National Cancer Institute funding by 25% annually for FY2026-2030 to match cancers mortality toll and direct a report on drug shortages. Health Disparities Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Health Equity and Accountability Act. This bill advances policies to reduce health disparities and improve cancer prevention, research, and care for underserved communities. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Lainie Jones Comprehensive Cancer Survivorship Act, H.R. 8839. The bill would create pathways to address the financial challenges of cancer survivorship and maintain patients access to the health services needed to address the long-term effects of cancer. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Charity Parity Act, H.R. 8783, S. 4511. The bill would allow taxpayers to make direct qualified charitable distributions (QCDs) from their employer sponsored retirement plans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010) Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13)(2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. OMBs proposed Regulation for Federal Financial Assistance (May 2026). The changes in federal regulations would risk politicizing federal grant awards by empowering appointees to override scientific merit reviews, delaying cancer research progress, reducing transparency, and threatening NIH/CDC-funded breakthroughs that save lives.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Asal Sayas National Strategy on Young Adult Cancers Act, S. 4717: Directs the NIH to develop a comprehensive national strategy to address the alarming rise of cancers in adults ages 18 to 49. American Cures Act, S. 4494. This bill would permanently fund several federal agencies and programs that perform biomedical research.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1) (2007-2023); Intern, Senator Barack Obama (D-IL) (2005)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson(D - FL 24) (2011)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, U.S. Representative Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1abdef3a-602b-4a5b-99cf-dcc7e733436d/","filing_uuid":"1abdef3a-602b-4a5b-99cf-dcc7e733436d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1abdef3a-602b-4a5b-99cf-dcc7e733436d/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-07-20T09:30:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act;; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; SHOWER Act; Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 2165, Choice in Automobile Retail Sales Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 2140, Diesel Emissions Reduction Act of 2025; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; S 4732, Wildfire Smoke Emergency Declaration Act; HR 9243, Wildfire Smoke Emergency Declaration Act; HR 9453, End EPA Abuse Act; S 4931, End EPA Abuse Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 6387, Fire Improvement and Reforming Exceptional Events Act; HR 6409, Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; HR 1346, To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes; S 4404, No Passes for Polluters Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act;;; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; ;; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program;; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1abdef3a-602b-4a5b-99cf-dcc7e733436d/","filing_uuid":"1abdef3a-602b-4a5b-99cf-dcc7e733436d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1abdef3a-602b-4a5b-99cf-dcc7e733436d/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Laura Katherine Bender","dt_posted":"2026-07-20T09:30:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Ave NW","registrant_address_2":"Suite 1425 North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":2811,"url":"https://lda.gov/api/v1/registrants/2811/","house_registrant_id":30549,"name":"AMERICAN LUNG ASSOCIATION","description":null,"address_1":"1331 Pennsylvania Ave NW","address_2":"Suite 1425 North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA BENDER","contact_telephone":"+1 202-715-3457","dt_updated":"2026-07-20T09:13:00.293676-04:00"},"client":{"id":103597,"url":"https://lda.gov/api/v1/clients/103597/","client_id":12,"name":"AMERICAN LUNG ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to \"Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment\"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to \"New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule\"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled \"Reconsideration of the National Ambient Air Quality Standards for Particulate Matter\"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to \"Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020\"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act;; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; SHOWER Act; Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 2165, Choice in Automobile Retail Sales Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 2140, Diesel Emissions Reduction Act of 2025; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; S 4732, Wildfire Smoke Emergency Declaration Act; HR 9243, Wildfire Smoke Emergency Declaration Act; HR 9453, End EPA Abuse Act; S 4931, End EPA Abuse Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 6387, Fire Improvement and Reforming Exceptional Events Act; HR 6409, Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; HR 1346, To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes; S 4404, No Passes for Polluters Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":33,"name":"Energy, Dept of"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act;;; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; ;; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program;; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152574,"prefix":null,"prefix_display":null,"first_name":"NATALIA","nickname":null,"middle_name":null,"last_name":"REYES BECERRA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150198,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"ANNE MUELLER","last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141328,"prefix":"mrs","prefix_display":"MRS.","first_name":"RANJANA","nickname":null,"middle_name":null,"last_name":"KODWANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d97532a4-158d-4e42-b6f6-76d21bbdd36f/","filing_uuid":"d97532a4-158d-4e42-b6f6-76d21bbdd36f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d97532a4-158d-4e42-b6f6-76d21bbdd36f/print/","filing_document_content_type":"text/html","income":null,"expenses":"530000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Matt Willams, Vice President US Government Affairs","dt_posted":"2026-07-20T15:36:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"6555 State Highway 161","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Irving","registrant_state":"TX","registrant_zip":"75039","registrant":{"id":24566,"url":"https://lda.gov/api/v1/registrants/24566/","house_registrant_id":31313,"name":"MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY","description":null,"address_1":"6555 State Highway 161","address_2":null,"address_3":null,"address_4":null,"city":"Irving","state":"TX","state_display":"Texas","zip":"75039","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT WILLIAMS","contact_telephone":"+1 972-446-4800","dt_updated":"2026-10-21T11:54:10.352735-04:00"},"client":{"id":132410,"url":"https://lda.gov/api/v1/clients/132410/","client_id":12,"name":"MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-09"},"lobbying_activities":[{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"H.R. 2444, Promoting Resilient Supply Chains Act; S.257, Promoting Resilient Supply Chains","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146847,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"BUCKLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148622,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":80345,"prefix":null,"prefix_display":null,"first_name":"JOSHUA","nickname":null,"middle_name":"C","last_name":"BABB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149850,"prefix":null,"prefix_display":null,"first_name":"DIANA","nickname":null,"middle_name":null,"last_name":"FELNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149849,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BRANTON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); S. 3822, Break Up Big Medicine Act; Issues related to support for independent physician practices, community pharmacies, and community-based care; Drug Shortages; Safe Step Act (Support establishing an exception to medication step-therapy protocol in specified cases).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":80345,"prefix":null,"prefix_display":null,"first_name":"JOSHUA","nickname":null,"middle_name":"C","last_name":"BABB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148622,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61981,"prefix":null,"prefix_display":null,"first_name":"BEN","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140654,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146847,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"BUCKLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149849,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BRANTON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink","new":false},{"lobbyist":{"id":149850,"prefix":null,"prefix_display":null,"first_name":"DIANA","nickname":null,"middle_name":null,"last_name":"FELNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150570,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"RICHARDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61981,"prefix":null,"prefix_display":null,"first_name":"BEN","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140654,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150570,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"RICHARDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149850,"prefix":null,"prefix_display":null,"first_name":"DIANA","nickname":null,"middle_name":null,"last_name":"FELNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149849,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BRANTON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink","new":false},{"lobbyist":{"id":80345,"prefix":null,"prefix_display":null,"first_name":"JOSHUA","nickname":null,"middle_name":"C","last_name":"BABB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148622,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R. 3164, Ensuring Community Access to Pharmacist Services Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":80345,"prefix":null,"prefix_display":null,"first_name":"JOSHUA","nickname":null,"middle_name":"C","last_name":"BABB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148622,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146847,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"BUCKLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149849,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BRANTON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink","new":false},{"lobbyist":{"id":149850,"prefix":null,"prefix_display":null,"first_name":"DIANA","nickname":null,"middle_name":null,"last_name":"FELNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/956076c6-86a3-42ed-bf18-8375d3295b7b/","filing_uuid":"956076c6-86a3-42ed-bf18-8375d3295b7b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/956076c6-86a3-42ed-bf18-8375d3295b7b/print/","filing_document_content_type":"text/html","income":null,"expenses":"7360000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Paul J. Larsen","dt_posted":"2026-07-20T15:46:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"670 Maine Avenue, SW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":31350,"url":"https://lda.gov/api/v1/registrants/31350/","house_registrant_id":30654,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","description":null,"address_1":"670 Maine Avenue, SW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL J. LARSEN","contact_telephone":"+1 202-835-3400","dt_updated":"2026-07-30T11:08:37.463508-04:00"},"client":{"id":138226,"url":"https://lda.gov/api/v1/clients/138226/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S.___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S.___: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S.___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Presidents Budget Fiscal Year 2027 Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act H.R. 9661: Expedited Access to Biosimilars Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 6089: Biomanufacturing Excellence Act of 2025 H.R. 9102: Biotech Investment National Security Act of 2026 (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/31a9f398-c7a7-43ef-a970-78313480cf30/","filing_uuid":"31a9f398-c7a7-43ef-a970-78313480cf30","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/31a9f398-c7a7-43ef-a970-78313480cf30/print/","filing_document_content_type":"text/html","income":null,"expenses":"1440000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jane Adams","dt_posted":"2026-07-20T16:01:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"ONE JOHNSON & JOHNSON PLAZA","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"NEW BRUNSWICK","registrant_state":"NJ","registrant_zip":"08933","registrant":{"id":20686,"url":"https://lda.gov/api/v1/registrants/20686/","house_registrant_id":30348,"name":"JOHNSON & JOHNSON SERVICES, INC.","description":null,"address_1":"ONE JOHNSON & JOHNSON PLAZA","address_2":null,"address_3":null,"address_4":null,"city":"NEW BRUNSWICK","state":"NJ","state_display":"New Jersey","zip":"08933","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JANE ADAMS","contact_telephone":"+1 202-589-1000","dt_updated":"2026-07-30T18:01:40.268804-04:00"},"client":{"id":126906,"url":"https://lda.gov/api/v1/clients/126906/","client_id":12,"name":"JOHNSON & JOHNSON SERVICES INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"S.4784/H.R. 8800 National Defense Authorization Act (NDAA), regarding provision prohibiting Department of Defense (DOD) contracted companies from engaging in stock buybacks and issuing shareholder dividends absent a waiver from the Secretary","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71075,"prefix":null,"prefix_display":null,"first_name":"LARRY","nickname":null,"middle_name":null,"last_name":"CAMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71075,"prefix":null,"prefix_display":null,"first_name":"LARRY","nickname":null,"middle_name":null,"last_name":"CAMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73113,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"PINKELE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150724,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":null,"last_name":"KALUSNIAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153683,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"LAST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153684,"prefix":null,"prefix_display":null,"first_name":"FOLASHADE","nickname":null,"middle_name":null,"last_name":"WILSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153685,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"CLARKIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"- Issues related to stroke care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153685,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"CLARKIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"- H.R. 2483, \"SUPPORT for Patients and Communities Reauthorization Act of 2025\", regarding all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"H.R.8413, the SECURE Data Act, regarding all provisions Issues related to - artificial intelligence - data privacy - cybersecurity - robotics","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax - use of excess pension funds","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"- Issues related to USMCA review and renegotiation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/de199a3f-c639-4cc1-beb6-4983f4040b52/","filing_uuid":"de199a3f-c639-4cc1-beb6-4983f4040b52","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/de199a3f-c639-4cc1-beb6-4983f4040b52/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Ronald M. Jacobs, Partner","dt_posted":"2026-07-20T18:28:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"600 Massachusetts Avenue NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":39941,"url":"https://lda.gov/api/v1/registrants/39941/","house_registrant_id":31958,"name":"VENABLE LLP","description":"Law firm","address_1":"600 Massachusetts Avenue NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RONALD M. JACOBS","contact_telephone":"+1 202-344-4000","dt_updated":"2026-07-27T16:10:38.817219-04:00"},"client":{"id":50763,"url":"https://lda.gov/api/v1/clients/50763/","client_id":50763,"name":"PATIENT ACCESS NETWORK FOUNDATION","general_description":"Non-profit, charitable patient assistance program","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-18"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Prohibiting copay accumulators in ACA Exchange plans: Help Ensure Lower Patient (HELP) Copays Act (H.R. 6423 / S. 864); Transparency and streamline utilization management protocols including prior authorization and step therapy, Safe Step Act, and Improving Senior's Timely Access to Care Act; Increase CMS outreach and education on the Medicare Prescription Payment Program, Increasing Medication Access for Seniors Act (H.R. 6401); Increase participation in clinical trials; Clinical Trials Modernization Act (H.R. 3521 / S. 4440).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138109,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":"A","last_name":"HANEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5853e0f4-c29f-4c7a-a723-d76b354a862b/","filing_uuid":"5853e0f4-c29f-4c7a-a723-d76b354a862b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/5853e0f4-c29f-4c7a-a723-d76b354a862b/print/","filing_document_content_type":"text/html","income":null,"expenses":"22000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Timothy Clement","dt_posted":"2026-07-21T10:44:17-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"500 Montgomery Street","registrant_address_2":"Suite 820","registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":28195,"url":"https://lda.gov/api/v1/registrants/28195/","house_registrant_id":32140,"name":"MENTAL HEALTH AMERICA","description":null,"address_1":"2000 North Beauregard Street","address_2":"6th Floor","address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22311","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NATHANIEL COUNTS","contact_telephone":"+1 703-797-2583","dt_updated":"2024-07-22T14:54:01.761266-04:00"},"client":{"id":134498,"url":"https://lda.gov/api/v1/clients/134498/","client_id":12,"name":"MENTAL HEALTH AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1996-02-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Early Action and Responsiveness Lifts Youth Minds Act H.R. 1735/S.779. Legislation that would allow states to use up to 5% of the Mental Health Block Grant for evidence-based mental health prevention and early intervention activities. COMPLETE Care Act (S.931/H.R.2509). This bill would increase Medicare reimbursement amounts for the HCPCS billing codes for integrated behavioral health care for three years. The HCPCS codes are 99484, 99492, 99493, 99494, G2214, and G0323. Reimbursement would be 175% of current rates for 2027, 150% for 2028, and 125% for 2029. Promoting Effective and Empowering Recovery Services in Medicare Act H.R. 6841/S. 3521. This bill would allow for Medicare reimbursement for mental health and substance use disorder peer support specialists. Expanding Community Access to Health Services Act H.R. 8201. This bill requires community health centers to provide mental health and substance use disorder services.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146924,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"CLEMENT","suffix":null,"suffix_display":null},"covered_position":"Vice President of Federal Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill (H.R. 1). Specifically, lobbying House Energy and Commerce and Senate HELP committees to ask administration to clarify the effect of 42 CFR Part 2 on ex-parte verifications of individuals who are exempt from community engagement requirements.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146924,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"CLEMENT","suffix":null,"suffix_display":null},"covered_position":"Vice President of Federal Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Mental Health Substance use disorder H.R. 1, One Big Beautiful Bill Act; specifically, lobbying to amend Medicaid community engagement requirements to require states to perform ex parte verifications for individuals eligible for exceptions due to having a substance use disorder; lobbying House Energy and Commerce (majority and minority) and Senate HELP (majority and minority) on legislative language related to ex-parte verifications and 42 CFR Part 2 that would improve implementation of H.R. 1","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146924,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"CLEMENT","suffix":null,"suffix_display":null},"covered_position":"Vice President of Federal Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations for Mental Health Block Grant at levels contained within House Labor HHS FY27 bill that passed out of the full appropriations committee on 6/9/2026, along with language in accompanying report for SAMHSA to work with states to pursue prevention and early intervention activities with MHBG funding. Appropriations for Parity Enforcement Grants within Center for Consumer Information and Insurance Oversight","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146924,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"CLEMENT","suffix":null,"suffix_display":null},"covered_position":"Vice President of Federal Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}